Mesa Emergency Solutions

Name

Mesa Emergency Solutions

Legal name

Mesa Emergency Solutions

Website

https://mesaemergencysolutions.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Mesa Emergency Solutions is a private, early-stage pharmaceutical company developing emergency use combination products that integrate pharmaceutical science with drug delivery technology, targeting hospitals, EMS, and healthcare providers through a partnership-based B2B licensing model.

Ownership category

akta.pro rank

Product category

Emergency Pharmaceuticals

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN)

Keywords

• Emergency pharmaceuticals
• Combination drug delivery
• Pharmaceutical drug delivery
• Emergency medical products
• Life-saving pharmaceuticals

Headquarters

HQ city

Frederick

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Emergency Use Combination Products: Development and commercialization of life-saving emergency use pharmaceutical combination products leveraging proprietary drug delivery technology. Revenue is generated through product partnerships, licensing, and direct commercial arrangements with healthcare organizations requiring emergency medical solutions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Mesa Emergency Solutions develops and commercializes life-saving emergency use combination products by combining world-class pharmaceutical science with drug delivery technology. The company focuses on creating specialized pharmaceutical products designed for emergency use applications, delivered to healthcare organizations through partnership-based commercial arrangements.

Differentiator

Problem solved

Functional benefit

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Others

• West Pharmaceutical Services: Leading supplier of drug delivery components including auto-injector and prefilled syringe systems used in emergency combination products. An enabling infrastructure provider whose technology stack underpins products like those Mesa is developing.

Broad incumbents

• Emergent BioSolutions: Large specialty biopharmaceutical company focused on emergency medical countermeasures (e.g., Narcan, BioThrax). Operates broadly in the same emergency use pharmaceutical space Mesa targets, but at vastly greater scale and with established commercialization.
• Hikma Pharmaceuticals: Global specialty pharmaceutical manufacturer with a strong injectables portfolio including emergency use products. Comparable in targeting emergency care injectables but operates at much broader scale across multiple geographies.
• Becton Dickinson (BD): Global medical technology company with a broad drug delivery and combination product device portfolio (auto-injectors, prefilled systems). A broad incumbent in the delivery technology layer relevant to Mesa's combination product model.
• Pfizer (incl. Meridian Medical Technologies): Manufactures EpiPen through subsidiary Meridian Medical Technologies, a flagship emergency use combination product. A broad incumbent competitor that defines the standard against which Mesa's combination product strategy must compete.

Emerging players

• Opiant Pharmaceuticals (acquired by Indivior): Specialty pharmaceutical company focused on opioid overdose and emergency antidote therapies. Comparable to Mesa in pursuing emergency use pharmaceutical products for high-urgency clinical scenarios.
• Adamis Pharmaceuticals: Specialty pharmaceutical company focused on emergency and respiratory products (e.g., Symjepi epinephrine injection). A smaller emerging player in the same emergency use combination product niche as Mesa.

Direct peers

• Amphastar Pharmaceuticals: Specialty injectable pharmaceutical company with a focus on emergency and difficult-to-formulate injectable products. Comparable to Mesa in combining drug formulation and delivery technology for emergency and acute care use cases.
• Antares Pharma (Halozyme): Drug delivery technology company specializing in self-injection and emergency-use injector platforms. Comparable to Mesa in combining proprietary drug delivery technology with pharmaceutical applications for emergency and self-administered therapies.
• kaleo (PharmaTher Holdings): Developer of emergency use auto-injector combination products (e.g., AUVI-Q epinephrine injector, naloxone). Directly comparable to Mesa as a drug-device combination product specialist serving emergency rescue scenarios.

Market position

Customer concentration

• LinkedInlinkedin.com/company/mesa-emergency-solutions

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mesa Emergency Solutions